ArticleInternational journal of molecular medicine2018

Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2‑mediated STAT3/PI3K/Akt signaling pathway.

Mei Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.